Global Retinoblastoma Treatment Market Set to Reach $4.20 Billion by 2034 with Steady Growth in Targeted Therapies and Gene Treatment
March 12, 2024 13:42 ET
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Retinoblastoma Treatment Market" report has been added to ResearchAndMarkets.com's offering.The global retinoblastoma treatment market size...
Global Bevacizumab Biosimilars Market Outlook 2024-2028 & 2033 Featuring Cipla, Reliance Lifesciences, Genentech, Fujifilm Kyowa Kirin Biologics, and Pfizer
March 06, 2024 07:30 ET
|
Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Bevacizumab Biosimilars Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The bevacizumab biosimilars market has...